Vaccine, Pomezia (Rome) is in pole position

fonte foto: Latina Oggi

According to epidemiologist Pier Luigi Lopalco, the Covid-19 vaccine produced in Pomezia (Rome), by the Advent division of IRBM in partnership with the Jenner Institute of Oxford, is one of those leading the race. IRBM capitalizes on its previous experience in the fight against Ebola; on the other hand the British university had already fought against Mers. The vaccine candidate of Oxford and Pomezia is advantaged because some already known platforms are being utilized for its development: Lopalco refers to viral vectors, then explains how this technology works.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.